Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. The use of arformoterol is pending revision due to safety concerns in regards to an increased risk of severe exacerbation of asthma symptoms, leading to hospitalization as well as death in some patients using long-acting beta agonists for the treatment of asthma. It is grouped under the following drug class(es): Beta-2 agonists. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include (-)-Formoterol, Atimos, Innovair and Fluir. Its PubChem CID is 3083544.
Arformoterol
| CAS No | 67346-49-0 |
|---|---|
| Molecular Formula | C19H24N2O4 |
| Molecular Weight | 344.4 g/mol |
| Synonyms | N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Arformoterol is a bronchodilator. It works by relaxing muscles in the airways to improve breathing. Arformoterol inhalation is used to prevent bronchoconstriction in people with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
The listed CAS number is 67346-49-0.
The listed molecular formula is C19H24N2O4.
The listed molecular weight is 344.4 g/mol.
N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide.
The source lists (-)-Formoterol, Atimos, Innovair and Fluir.